Claritas Pharmaceuticals (KALTF) News Today Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Charlottesville, VirginiaMay 5, 2024 | forbes.comDPHAY - Dechra Pharmaceuticals PLCJuly 6, 2023 | finance.yahoo.comAnimal Health Active Pharmaceutical Ingredients Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030June 22, 2023 | marketwatch.comACXP - Acurx Pharmaceuticals, Inc.June 21, 2023 | finance.yahoo.comPharmaceutical Lecithin Market Size, Growth, Outlook, Share, Segmentation Analysis, Revenue And Forecast 2031April 27, 2023 | marketwatch.comGeneric Drugs Market Share, Segmentation and Forecast 2023-2028March 17, 2023 | marketwatch.com2023 Pharmaceutical CDMO Services Market Segmentation and Targeting: Strategies for Success Forecast till 2028February 14, 2023 | marketwatch.com2023 Mifepristone Market Segmentation and Targeting: Strategies for Success Forecast till 2028February 13, 2023 | marketwatch.comRadioimmunotherapy Treatment Market Geographical Segmentation By Forecast Revenue 2023-2028January 19, 2023 | marketwatch.comClaritas Pharmaceuticals, Inc. (CLAZF)January 12, 2023 | finance.yahoo.comOnline Pharmaceuticals Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries DataJanuary 5, 2023 | marketwatch.comAnalgesics Market Global Investor, Latest Trends, Industry Growth, Size, Segmentation, Future Demands, by Regional Forecast to 2028November 30, 2022 | marketwatch.comPharmaceutical Sachet Market In 2022 : Industry Growth, Top Players, Segmentation and Forecast to 2028 with Top Countries DataSeptember 30, 2022 | marketwatch.comNew Claritas Report Reveals that the U.S. Hispanic Population Grew 89% Since 2000 – and Will Exceed 74 Million Consumers by 2028September 22, 2022 | finance.yahoo.comClaritas Pharmaceuticals IncSeptember 13, 2022 | reuters.comClaritas Pharmaceuticals Inc (CLAS)May 11, 2022 | investing.comKaya Now Appoints Stormy Simon As A Director Of The BoardMarch 12, 2022 | benzinga.comClaritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of FinancingFebruary 22, 2022 | finance.yahoo.comClaritas Anticipates Response from Australian Ethics Committee by February 18, 2022February 9, 2022 | finance.yahoo.comClaritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina PartnersJanuary 26, 2022 | finance.yahoo.comClaritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe BurnsJanuary 17, 2022 | finance.yahoo.comClaritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina PartnersJanuary 17, 2022 | finance.yahoo.comClaritas Pharmaceuticals signs $5M equity financing dealJanuary 12, 2022 | seekingalpha.comClaritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd.January 12, 2022 | finance.yahoo.comClaritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in NewbornsDecember 22, 2021 | finance.yahoo.comClaritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary DiseaseDecember 21, 2021 | finance.yahoo.comClaritas Announces Publication of Peer-Reviewed Article Reporting that R-107 Significantly Improved Multi-Organ Function and Survival in an Ovine (Sheep) Model of SepsisDecember 20, 2021 | finance.yahoo.comClaritas Provides Update Regarding Phase 1 Clinical StudyNovember 18, 2021 | finance.yahoo.comClaritas Announces Engagement of B. Riley Securities as Sponsor for the Company’s Planned Up-Listing of its Securities to the OTCQBNovember 4, 2021 | finance.yahoo.comClaritas Announces Closing of Convertible Debenture Financing with Obsidian Global GP, LLCOctober 19, 2021 | finance.yahoo.comCuraleaf Expands Edibles Portfolio With Select Snooze BitesOctober 15, 2021 | benzinga.comWhat Is Precision Psychiatry? Biotech Company Leverages New Approach To Mental Health DisordersOctober 13, 2021 | benzinga.comMichigan Cannabis Sales Still Up There: September Earnings Reach $161.4MOctober 13, 2021 | benzinga.comClaritas Announces Option to Acquire Rights to Novel Drug for Treatment of COVID-19 Related ARDSSeptember 16, 2021 | finance.yahoo.comThe Bio Revolution of Medical Cannabinoid TherapeuticsSeptember 13, 2021 | benzinga.comNational Expungement Works Returns With Annual Weeklong Legal Relief CampaignSeptember 9, 2021 | benzinga.comHow Long Does Marijuana Stay In Your System?September 5, 2021 | benzinga.comClaritas Pharmaceuticals, Inc. (KALTD)August 20, 2021 | au.finance.yahoo.comClaritas Announces Grant of Stock Options to Directors and OfficersJuly 27, 2021 | finance.yahoo.comClaritas Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with ...July 27, 2021 | apnews.comClaritas Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe COVID-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107July 26, 2021 | finance.yahoo.com Get Claritas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KALTF and its competitors with MarketBeat's FREE daily newsletter. Email Address True paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. KALTF Media Mentions By Week KALTF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KALTF News Sentiment▼0.000.43▲Average Medical News Sentiment KALTF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KALTF Articles This Week▼00▲KALTF Articles Average Week Get Claritas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KALTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Ascentage Pharma Group International News Ascletis Pharma News Avacta Group News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KALTF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Claritas Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Claritas Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KALTF Stock Alerts